Impact of Tumor and Immunological Heterogeneity on the Anti-Cancer Immune Response
Carolyn Shembrey(Peter MacCallum Cancer Centre), Frédéric Hollande(The University of Melbourne)
Cited by 48
Related Papers
Targeting of TP53-independent cell cycle checkpoints overcomes FOLFOX resistance in Metastatic Colorectal Cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2021|6